These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10519244)

  • 1. Cryptosporidium parvum: lectins mediate irreversible inhibition of sporozoite infectivity in vitro.
    Gut J; Nelson RG
    J Eukaryot Microbiol; 1999; 46(5):48S-49S. PubMed ID: 10519244
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryptosporidium parvum: synchronized excystation in vitro and evaluation of sporozoite infectivity with a new lectin-based assay.
    Gut J; Nelson RG
    J Eukaryot Microbiol; 1999; 46(5):56S-57S. PubMed ID: 10519247
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of a Gal/GalNAc-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction.
    Joe A; Hamer DH; Kelley MA; Pereira ME; Keusch GT; Tzipori S; Ward HD
    J Eukaryot Microbiol; 1994; 41(5):44S. PubMed ID: 7804243
    [No Abstract]   [Full Text] [Related]  

  • 4. Preferential infection of dividing cells by Cryptosporidium parvum.
    Widmer G; Yang YL; Bonilla R; Tanriverdi S; Ciociola KM
    Parasitology; 2006 Aug; 133(Pt 2):131-8. PubMed ID: 16623967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptosporidium parvum sporozoites deposit trails of 11A5 antigen during gliding locomotion and shed 11A5 antigen during invasion of MDCK cells in vitro.
    Gut J; Nelson RG
    J Eukaryot Microbiol; 1994; 41(5):42S-43S. PubMed ID: 7528594
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of carbohydrates and lectins on cryptosporidial sporozoite penetration of cultured cell monolayers.
    Kuhls TL; Mosier DA; Crawford DL
    J Protozool; 1991; 38(6):74S-76S. PubMed ID: 1818216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells.
    Chen XM; LaRusso NF
    Gastroenterology; 2000 Feb; 118(2):368-79. PubMed ID: 10648465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Die-off of Cryptosporidium parvum in soil and wastewater effluents.
    Nasser AM; Tweto E; Nitzan Y
    J Appl Microbiol; 2007 Jan; 102(1):169-76. PubMed ID: 17184332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in Cryptosporidium parvum oocyst infectivity in vitro by using the membrane filter dissolution method for recovering oocysts from water samples.
    Carreno RA; Pokorny NJ; Weir SC; Lee H; Trevors JT
    Appl Environ Microbiol; 2001 Jul; 67(7):3309-13. PubMed ID: 11425759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptosporidium excystation and invasion: getting to the guts of the matter.
    Smith HV; Nichols RA; Grimason AM
    Trends Parasitol; 2005 Mar; 21(3):133-42. PubMed ID: 15734661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptosporidium parvum: identification of a new surface adhesion protein on sporozoite and oocyst by screening of a phage-display cDNA library.
    Yao L; Yin J; Zhang X; Liu Q; Li J; Chen L; Zhao Y; Gong P; Liu C
    Exp Parasitol; 2007 Apr; 115(4):333-8. PubMed ID: 17097085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved in vitro infection model for viability testing of Cryptosporidium parvum oocysts.
    Najdrowski M; Joachim A; Daugschies A
    Vet Parasitol; 2007 Nov; 150(1-2):150-4. PubMed ID: 17949908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets for detection and immunotherapy in Cryptosporidium parvum.
    Boulter-Bitzer JI; Lee H; Trevors JT
    Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial adhesion of Cryptosporidium parvum: identification of a colostrum-derived inhibitory lipid.
    Schmidt J; Kuhlenschmidt MS
    Mol Biochem Parasitol; 2008 Nov; 162(1):32-9. PubMed ID: 18675305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot-scale evaluation of UV reactors' efficacy against in vitro infectivity of Cryptosporidium parvum oocysts.
    Entrala E; Garin YJ; Meneceur P; Hayat M; Scherpereel G; Savin C; Féliers C; Derouin F
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):555-61. PubMed ID: 17941833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and potential use of a Cryptosporidium parvum virus (CPV) antigen for detecting C. parvum oocysts.
    Kniel KE; Higgins JA; Trout JM; Fayer R; Jenkins MC
    J Microbiol Methods; 2004 Aug; 58(2):189-95. PubMed ID: 15234516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Cryptosporidium parvum infection of a mammalian cell culture by recombinant scFv antibodies.
    Pokorny NJ; Boulter-Bitzer JI; Hall JC; Trevors JT; Lee H
    Antonie Van Leeuwenhoek; 2008 Oct; 94(3):353-64. PubMed ID: 18581250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of UV-induced thymine dimers in individual Cryptosporidium parvum and Cryptosporidium hominis oocysts by immunofluorescence microscopy.
    Al-Adhami BH; Nichols RA; Kusel JR; O'Grady J; Smith HV
    Appl Environ Microbiol; 2007 Feb; 73(3):947-55. PubMed ID: 17012589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heavy cryptosporidial infections in children in northeast Brazil: comparison of Cryptosporidium hominis and Cryptosporidium parvum.
    Bushen OY; Kohli A; Pinkerton RC; Dupnik K; Newman RD; Sears CL; Fayer R; Lima AA; Guerrant RL
    Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):378-84. PubMed ID: 16934303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of infectious Cryptosporidium oocysts by cell culture immunofluorescence assay: applicability to environmental samples.
    Schets FM; Engels GB; During M; de Roda Husman AM
    Appl Environ Microbiol; 2005 Nov; 71(11):6793-8. PubMed ID: 16269711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.